The Board

A unique combination of talents

We are a group of scientists, medical professionals and entrepreneurs who have come together to solve one of the world’s toughest and most urgent medical challenges.

Our unique combination of talents has made it possible to turn a breakthrough technology into an effective weight loss solution. Science and medicine coming together to deliver results neither could have achieved alone.

A team of the brightest minds in business, science and surgery.

Dr Hutan Ashrafian a pioneering bariatric surgeon, realised that they could combine their expertise to create something genuinely new to help people with weight loss. Dr Camilla Easter and Dr Nick Edwards, two medically trained entrepreneurs, joined Oxford Medical Products to turn this vision into a reality.

Team Members

CEO - Dr Camilla Easter

CEO - Dr Camilla Easter

Dr Camilla Easter, has six years biotech start-up experience as COO working exclusively on hydrogel based medical devices. Originally a veterinary surgeon, she has run veterinary clinical trials and launched the veterinary arm of a biotech company. Following on from this she moved into the human biotech sector, here she was involved with all aspects of the company including, R&D, fundraising, regulatory and preclinical trials for medical devices.

BD Director - Dr David Jackson

BD Director - Dr David Jackson

Dr David Jackson has over twenty-five years’ experience of early stage high technology companies. He has a proven track record of business development and international management, having played a leading role in taking Oxford Molecular Group plc from start up to a major international company. He has operated at board level as Chairman, CEO and COO.

Chairman - Dr Nicholas Edwards

Chairman - Dr Nicholas Edwards

Dr Nicholas Edwards completed his training in Clinical Medicine at Oxford. He spent 18 years with Accenture and was the global leader of Accenture’s Pharmaceutical R&D business. He is chairman of Prescient Healthcare group and an investor and supporter of several life science start-ups.

CMO - Dr Hutan Ashrafian

CMO - Dr Hutan Ashrafian

Dr Hutan Ashrafian has a MRCS and PhD in surgery and computational physiology. Hutan is currently a clinical lecturer in surgery at Imperial College. His research objectives are to develop innovative and technological strategies to resolve the global, healthcare burden of obesity, metabolic syndrome, obesity-related cardiorespiratory disease, musculoskeletal dysfunction and cancer.

Robert Thong

Robert Thong

Robert has over 30 years experience working with over 100 different organizations across the biopharma and medical technology sectors, specialising in B2B collaborations and commercialising life science innovations. He is a Partner in Selvedge Venture, Chairman & Chief Executive of Multiomic Health, Investor/Advisor to Mesh Bio and Non-Executive Director of Curiosity. Previous roles include leading global consultancy businesses and non-executive board positions at a US-listed pharmaceutical group and various venture capital-backed healthcare startups.

Close
Close
Sign in
Close
Cart (0)

No products in the basket. No products in the basket.